Home/SEC 13D/G/SLXNSEC 13D/GSLXN - Silexion Therapeutics Corp - SEC Filing Update (19-AUG-2026) | ThinkSabio - Stocks Simplified$SLXN$0.40▼ -97.91% YTDHealthcareAug 20, 2026 · ThinkSabio BlogSEC Filing Update: #SLXN Silexion Therapeutics Corp : $0.40 Sector: Healthcare | YTD: 🔽 -97.91% The SEC disclosed Today (19-AUG-2026) that Moringa Sponsor, LP has INCREASED #SLXN Shares by 599.22% 🟢 * Previous Holdings: 199.05K Shares * Current Holdings: 1.39M Shares * Increase+1.19M * Increased(%)+599.22% * Ownership: 25.0% * Estimated Investment Value: $1.04M https://www.thinksabio.com/reports/isr/SLXN Institutional ownership in #SLXN has been steadily rising over the past 4 quarters in Shares: Q3 2025: 508.00 Q4 2025: 1.83K Q1 2026: 3.65K Q2 2026: 17.06K Moringa Sponsor, LP increased its shareholding in Salient Technologies Limited from 199,053 shares to 1,391,827 shares, representing 25.0% ownership. Share this post🔗Copy LinkMore filings for $SLXNSLXN - Silexion Therapeutics Corp - SEC Filing Update (18-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 18, 2026$SLXN SEC Filing Update (23-JUN-2026) | ThinkSabio - Stocks SimplifiedJun 23, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G